COVID-19 treatment candidate headed to clinical trial in 2022
Q BioMed reports it expects candidate MAN-19, intended to treat COVID-19-related Acute Respiratory Distress Syndrome, to enter trials early next year.
Archives for September 28, 2021
Eli Lilly partners with Care Access to increase trial diversity
The pharmaceutical firm has tapped the decentralized research organization in order to help elevate the inclusivity of its oncology trials at all levels.
CROs facing formidable challenges in clinical research: survey
Conducted by patient services specialist Greenphire, the survey checks in with contract research organizations and shows how they are approaching obstacles.